Format

Send to

Choose Destination
Hum Mol Genet. 2017 Oct 1;26(R2):R237-R245. doi: 10.1093/hmg/ddx210.

Review: placental biomarkers for assessing fetal health.

Author information

1
BC Children's Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada.
2
Department of Medical Genetics, University of British Columbia, Vancouver, BC V6H 3N1, Canada.

Abstract

The placenta is a multifunctional organ that regulates key aspects of pregnancy maintenance and fetal development. As the placenta is in direct contact with maternal blood, cellular products (DNA, RNA, proteins, etc.) from the placenta can enter maternal circulation by a variety of ways. The application of serum proteins and circulating placental derived DNA has been well demonstrated for the diagnosis of aneuploidy, and there is great interest in exploring the use of placental biomarkers for the prediction of a range of fetal health parameters. In this review, we discuss how placental biomarkers might be used for the diagnosis and early detection of preeclampsia, fetal growth restriction and inflammation associated with preterm birth. We emphasize how increased understanding of the underlying placental biology can aid in the interpretation of such approaches and development of new biomarkers that can help predict the onset of pregnancy and neonatal health concerns before they manifest.

PMID:
28595268
DOI:
10.1093/hmg/ddx210
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center